We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VSTM market cap is 386.15M. The company's latest EPS is USD -2.5373 and P/E is -2.96.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 10M | 0 | 0 |
| Operating Income | -31.14M | -28.06M | -18.28M | -37.03M | -31.59M |
| Net Income | -27.37M | -33.86M | -8.26M | -23.97M | -64.55M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 88.52M | 2.05M | 2.6M | 0 | 10M |
| Operating Income | -49.36M | -61.41M | -72.94M | -92.08M | -114.96M |
| Net Income | -67.73M | -71.2M | -73.81M | -87.37M | -130.64M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 149.72M | 123.54M | 105.75M | 126.38M | 101.54M |
| Total Liabilities | 71.19M | 77.32M | 65.74M | 94.16M | 130.43M |
| Total Equity | 57.37M | 25.06M | 18.85M | 11.06M | -28.89M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 154.35M | 108.66M | 95.05M | 149.72M | 101.54M |
| Total Liabilities | 39.08M | 21.1M | 47.66M | 71.19M | 130.43M |
| Total Equity | 115.27M | 87.56M | 47.39M | 57.37M | -28.89M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -86.46M | -28.31M | -55.88M | -79.67M | -104.77M |
| Investing | -44.45M | 30.98M | 59.97M | 59.97M | 59.97M |
| Financing | 134.19M | 846k | 441k | 54.04M | 54.78M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.51M | -53.5M | -63.67M | -86.46M | -104.77M |
| Investing | -47.36M | 87k | 66.19M | -44.45M | 59.97M |
| Financing | 69.63M | 6.89M | 51.78M | 134.19M | 54.78M |
| Market Cap | 386.15M |
| Price to Earnings Ratio | -2.96 |
| Price to Sales Ratio | 38.62 |
| Price to Cash Ratio | 4.35 |
| Price to Book Ratio | -13.36 |
| Dividend Yield | - |
| Shares Outstanding | 51.49M |
| Average Volume (1 week) | 1.26M |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | -17.81% |
| 52 Week High | 13.52 |
| 52 Week Low | 2.10 |
| Spread (Intraday) | 0.05 (0.67%) |
| Company Name | Verastem Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.verastem.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
